SKYCLARYS Hard capsule Ref.[108533] Active ingredients: Omaveloxolone

Source: European Medicines Agency (EU)  Revision Year: 2024  Publisher: Reata Ireland Limited, Block A, Georges Quay Plaza, Georges Quay, Dublin 2, D02 E440 Ireland

Product name and form

Skyclarys 50 mg hard capsules.

Pharmaceutical Form

Hard capsule.

Opaque hard capsule with “RTA 408” printed on the light green body in white ink and “50” printed on the blue cap in white ink. Capsules (size 0) are 21.7 ± 0.3 mm in length, and the outer diameter of the cap is 7.64 ± 0.06 mm.

Qualitative and quantitative composition

Each hard capsule contains 50 mg omaveloxolone.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Omaveloxolone

The precise mechanism by which omaveloxolone exerts its therapeutic effect in patients with Friedreich’s ataxia is unknown. Omaveloxolone has been shown to activate the Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) pathway in vitro and in vivo in animals and humans. The Nrf2 pathway is involved in the cellular response to oxidative stress. There is substantial evidence that Nrf2 levels and activity are suppressed in cells from patients with Friedreich’s ataxia.

List of Excipients

Capsule contents:

Pregelatinized maize starch
Microcrystalline cellulose
Croscarmellose sodium
Magnesium stearate
Silica, colloidal anhydrous

Capsule shell:

Hypromellose
Titanium dioxide (E171)
Brilliant Blue FCF (E133)
Ferric oxide yellow (E172)
Printing ink
Shellac (E904)
Titanium dioxide (E171)

Pack sizes and marketing

High density polyethylene bottles with child-resistant, foil induction-sealed polypropylene closure.

Pack size of 90 capsules.

Pack size of 270 (3 packs of 90) capsules.

Not all pack sizes may be marketed.

Marketing authorization holder

Reata Ireland Limited, Block A, George’s Quay Plaza, George’s Quay, Dublin 2, D02 E440 Ireland

Marketing authorization dates and numbers

EU/1/23/1786/001
EU/1/23/1786/002

Drugs

Drug Countries
SKYCLARYS Austria, France, Croatia, Lithuania, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.